McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer...( DETROIT April 11 -- The McCarty ...),Health

DETROIT, April 11 /PRNewswire-USNewswire/ -- The McCarty Cancer Foundation has awarded Jeffrey Zonder, M.D., Assistant Professor of Medicine and Oncology, Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, a $50,000 grant for the multi-center Multiple Myeloma Clinical Research Initiative coordinated by Karmanos. This first-of-its-kind program, initiated by Dr. Zonder, is a collaboration with other cancer centers, locally and nationally, to increase the accessibility of new and novel therapies for patients with multiple myeloma and related conditions.

(Logo:

http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELOG O)

Roberta McCarty, president of the McCarty Cancer Foundation awarded Dr. Zonder the $50,000 grant in support of the Myeloma Research Program.

McCarty stated, "We are grateful to Dr. Zonder and his team for their commitment and dedication to multiple myeloma research, and to the Karmanos Cancer Institute for its commitment to a future free of cancer."

Michigan health centers participating in this research in addition to the Karmanos Cancer Institute include: Henry Ford Hospital, Sparrow Hospital, Providence Hospital and the Van Andel Research Institute. Nationally, Duke University, Ohio State University, Emory Winship Cancer Institute, the Cleveland Clinic and the University of Pittsburgh have also joined the project to date.

Multiple myeloma is a cancer of the bone marrow involving malignant plasma cells. According to the American Cancer Society, there will be approximately 19,920 new cases of multiple myeloma in the United States in 2008. Of these, about 11,190 will be in men and about 8,730 in women. About 10,690 Americans are expected to die of multiple myeloma in 2008. Additionally, a smaller number of people are affected by related diseases, such
'/>"/>